These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 29026967)

  • 1. A rat model of FOLFOX-induced neuropathy: effects of oral dimiracetam in comparison with duloxetine and pregabalin.
    Di Cesare Mannelli L; Maresca M; Micheli L; Farina C; Scherz MW; Ghelardini C
    Cancer Chemother Pharmacol; 2017 Dec; 80(6):1091-1103. PubMed ID: 29026967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of neuropathic pain induced by sorafenib in the rat: Effect of dimiracetam.
    Di Cesare Mannelli L; Maresca M; Farina C; Scherz MW; Ghelardini C
    Neurotoxicology; 2015 Sep; 50():101-7. PubMed ID: 26254739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad spectrum and prolonged efficacy of dimiracetam in models of neuropathic pain.
    Fariello RG; Ghelardini C; Di Cesare Mannelli L; Bonanno G; Pittaluga A; Milanese M; Misiano P; Farina C
    Neuropharmacology; 2014 Jun; 81():85-94. PubMed ID: 24486381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Collagen Conduit With Duloxetine and/or Pregabalin in the Management of Partial Peripheral Nerve Injury.
    Khan J; Alghamdi H; Anwer MM; Eliav E; Ziccardi V
    J Oral Maxillofac Surg; 2016 Jun; 74(6):1120-30. PubMed ID: 26878362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response profile in a rat model of exercise-induced hypoalgesia is associated with duloxetine, pregabalin and diclofenac effect on constriction-induced neuropathy.
    Khan J; Wang Q; Korczeniewska OA; McNeil R; Ren Y; Benoliel R; Eliav E
    Eur J Pain; 2023 Jan; 27(1):129-147. PubMed ID: 36198034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the anti-allodynic efficacy of a glycine transporter 2 inhibitor relative to pregabalin and duloxetine in a rat model of prostate cancer-induced bone pain.
    Imam MZ; Kuo A; Nicholson JR; Corradini L; Smith MT
    Pharmacol Rep; 2020 Oct; 72(5):1418-1425. PubMed ID: 32715433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of the Combination of Pregabalin with Duloxetine or Amitriptyline on the Pharmacokinetics and Antiallodynic Effect During Neuropathic Pain in Rats.
    Rodrigues RF; Kawano T; Placido RV; Costa LH; Podesta MHMC; Santos RS; Galdino G; Barros CM; Boralli VB
    Pain Physician; 2021 Jul; 24(4):E511-E520. PubMed ID: 34213877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine Protects against Oxaliplatin-Induced Neuropathic Pain and Spinal Neuron Hyperexcitability in Rodents.
    Kim W; Chung Y; Choi S; Min BI; Kim SK
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29206213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy of morphine, pregabalin, gabapentin, and duloxetine on mechanical allodynia is different from that on neuroma pain in the rat neuropathic pain model.
    Miyazaki R; Yamamoto T
    Anesth Analg; 2012 Jul; 115(1):182-8. PubMed ID: 22415534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Anti-Allodynic and Anti-Hyperalgesic Efficacy of a Glycine Transporter 2 Inhibitor Relative to Pregabalin, Duloxetine and Indomethacin in a Rat Model of Cisplatin-Induced Peripheral Neuropathy.
    Kuo A; Corradini L; Nicholson JR; Smith MT
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34202809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose-derived stem cells decrease pain in a rat model of oxaliplatin-induced neuropathy: Role of VEGF-A modulation.
    Di Cesare Mannelli L; Tenci B; Micheli L; Vona A; Corti F; Zanardelli M; Lapucci A; Clemente AM; Failli P; Ghelardini C
    Neuropharmacology; 2018 Mar; 131():166-175. PubMed ID: 29241656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats.
    Aoki M; Kurauchi Y; Mori A; Nakahara T; Sakamoto K; Ishii K
    Biol Pharm Bull; 2014; 37(2):322-6. PubMed ID: 24492729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Effects of Sokeikakketsuto on Chemotherapy-Induced Mechanical Allodynia and Cold Hyperalgesia in Rats.
    Nakamura H; Kawashiri T; Kobayashi D; Uchida M; Egashira N; Shimazoe T
    Biol Pharm Bull; 2021; 44(2):271-274. PubMed ID: 33518680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice.
    Sałat K; Cios A; Wyska E; Sałat R; Mogilski S; Filipek B; Więckowski K; Malawska B
    Pharmacol Biochem Behav; 2014 Jul; 122():173-81. PubMed ID: 24726707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antiallodynic activity of morphine, pregabalin and lidocaine in a rat model of neuropathic pain produced by one oxaliplatin injection.
    Ling B; Coudoré F; Decalonne L; Eschalier A; Authier N
    Neuropharmacology; 2008 Oct; 55(5):724-8. PubMed ID: 18598708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine ameliorates the impairment of diffuse noxious inhibitory control in rat models of peripheral neuropathic pain and knee osteoarthritis pain.
    Yoneda S; Kasai E; Matsuo M; Tamano R; Sakurai Y; Asaki T; Fujita M
    Neurosci Lett; 2020 Jun; 729():134990. PubMed ID: 32315711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing analgesic drugs from non-analgesic drugs based on brain activation in macaques with oxaliplatin-induced neuropathic pain.
    Shidahara Y; Natsume T; Awaga Y; Ogawa S; Yamoto K; Okamoto S; Hama A; Hayashi I; Takamatsu H; Magata Y
    Neuropharmacology; 2019 May; 149():204-211. PubMed ID: 30817933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.
    Carlos F; Espejel L; Novick D; López R; Flores D
    Medwave; 2015 Sep; 15(8):e6265. PubMed ID: 26460688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study.
    Bouhassira D; Wilhelm S; Schacht A; Perrot S; Kosek E; Cruccu G; Freynhagen R; Tesfaye S; Lledó A; Choy E; Marchettini P; Micó JA; Spaeth M; Skljarevski V; Tölle T
    Pain; 2014 Oct; 155(10):2171-9. PubMed ID: 25168665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment.
    Pacini A; Micheli L; Maresca M; Branca JJ; McIntosh JM; Ghelardini C; Di Cesare Mannelli L
    Exp Neurol; 2016 Aug; 282():37-48. PubMed ID: 27132993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.